Hyperglycemia and Lung Cancer-A Possible Relationship
Spasoje Popevic1,2, Nikola Maric2, Branislav Ilic1,2
1Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Diagnostics (Basel, Switzerland)
|March 28, 2025
Summary
High blood sugar (hyperglycemia) negatively impacts lung cancer patients, leading to worse outcomes and treatment complications. Understanding shared molecular pathways could improve lung cancer survival.
Area of Science:
- Oncology
- Metabolic Disorders
- Molecular Biology
Background:
- Glucose is the primary cellular energy source.
- Hyperglycemia is a common metabolic disorder with adverse effects on various diseases.
- Lung cancer presents significant treatment challenges due to high prevalence and mortality.
Purpose of the Study:
- To highlight the often-overlooked issue of hyperglycemia in lung cancer patients.
- To explore the link between hyperglycemia and lung cancer outcomes.
- To investigate common molecular pathways involved in both conditions.
Main Methods:
- Literature review of studies on hyperglycemia and lung cancer.
- Analysis of molecular signaling pathways common to both conditions.
- Correlation analysis between glycemic status and lung cancer patient outcomes.
Main Results:
- Hyperglycemia is prevalent in lung cancer patients but frequently overlooked.
- Unregulated blood glucose levels are associated with poorer lung cancer prognosis, reduced treatment efficacy, and increased complications.
- Multiple molecular pathways are implicated in both hyperglycemia and lung cancer, though direct correlations remain unclear.
Conclusions:
- Addressing hyperglycemia in lung cancer patients is crucial for improving therapeutic outcomes.
- Further research into shared molecular signaling pathways may reveal novel therapeutic targets.
- Understanding the interplay between glucose metabolism and lung cancer can enhance patient survival rates.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Psychoneuroimmunology: Diabetes and Cancer
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

